Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein Networks02:26

Protein Networks

4.5K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting antibody self-association with sequence-structure fusion models: the central role of CSI-BLI in early developability screening.

mAbs·2026
Same author

Accurate prediction of asparagine deamidation in biologics using advanced machine learning models.

Briefings in bioinformatics·2026
Same author

Early Salivary Gland Shrinkage Is Associated With an Increased Risk of Acute Xerostomia in Head and Neck Cancer Radiation Therapy.

Advances in radiation oncology·2026
Same author

Optimal radiotherapy dose scheduling with variable fraction sizes and breaks via sequential mixed-integer convex programming.

Physics and imaging in radiation oncology·2026
Same author

Adaptive and sequential cancer therapies emerge from treatment schedule optimization.

Research square·2026
Same author

Automation and digitalization in drug product process development.

Journal of pharmaceutical sciences·2026

Related Experiment Video

Updated: Jan 18, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.8K

Molecular phenotyping using networks, diffusion, and topology: soft tissue sarcoma.

James C Mathews1, Maryam Pouryahya2, Caroline Moosmüller3

  • 1Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, USA. mathewj2@mskcc.org.

Scientific Reports
|September 29, 2019
PubMed
Summary

This study introduces a novel unsupervised data analysis method for high-dimensional biological data, revealing distinct gene expression signatures in sarcomas. The approach aids in classifying tumor subtypes and identifying new molecular patterns.

More Related Videos

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.6K
A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.6K

Related Experiment Videos

Last Updated: Jan 18, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.8K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.6K
A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.6K

Area of Science:

  • Computational Biology
  • Bioinformatics
  • Data Science

Background:

  • Biological datasets, such as gene expression profiles, are often high-dimensional but contain underlying structures.
  • Analyzing complex biological networks and identifying patterns within them is crucial for understanding disease mechanisms.

Purpose of the Study:

  • To develop and apply an unsupervised data analysis methodology for multivariate biological datasets integrated with network information.
  • To identify coherent states or gene expression signatures within sarcoma data from The Cancer Genome Atlas (TCGA) along the TP53 signaling network.

Main Methods:

  • The methodology integrates network geometry (Wasserstein distance), global spectral analysis (diffusion maps), and topological data analysis (Mapper algorithm).
  • Applied to RNA-Seq gene expression profiles from sarcoma samples, focusing on genes within specific pathways or networks.
  • Analysis was performed along the TP53 (p53) signaling network.

Main Results:

  • The analysis successfully identified distinct gene expression signatures within sarcoma subtypes.
  • These signatures largely corresponded to known histological subtypes such as leiomyosarcoma, dedifferentiated liposarcoma (DDLPS), and synovial sarcoma.
  • A novel signature was discovered, characterized by the activation of SERPINE1 and inactivation of TP73.

Conclusions:

  • The developed unsupervised methodology effectively discerns biologically relevant states in high-dimensional gene expression data.
  • The identified signatures provide insights into sarcoma heterogeneity and can aid in subtype classification.
  • The discovery of a new molecular signature highlights the potential for identifying novel therapeutic targets or biomarkers.